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The bacterial lipopolysaccharide (LPS) is a biological activa-
tor that induces expression of multiple genes in several cell
types. LPS has been proposed as an etiopathogenic agent in
autoimmune diseases. However, whether LPS affects the ex-
pression of autoantigens has not been explored. Thyroglobu-
lin (TG) is a key protein in thyroid hormonogenesis and one
of the major thyroid autoantigens. This study aimed to ana-
lyze the action of LPS on TG gene expression in Fisher rat
thyroid cell line FRTL-5 thyroid cells. We demonstrate that
LPS increases the TSH-induced TG protein and mRNA level.
Evidence that the effect of LPS is exerted at the transcrip-
tional level was obtained by transfecting the minimal TG pro-
moter. The C element of the TG promoter, which contains
sequences for paired box domain transcription factor 8 (Pax8)
and thyroid transcription factor (TTF)-1 binding, is essential
for full TG promoter expression under TSH stimulation. The
transcriptional activity of a construct containing five tandem
repeats of the C site is increased by LPS, indicating a possible
involvement of the C site in the LPS-induced TG gene tran-
scription. We demonstrate that the TG promoter mutated at
the Pax8 or TTF-1 binding element in the C site does not
respond to LPS. In band shift assays, binding of Pax8 and
TTF-1 to the C site is increased by LPS. The Pax8 and TTF-1
mRNA and protein levels are augmented by LPS. The half-
lives of TG, Pax8, and TTF-1 are increased in endotoxin-
treated cells. Our results reveal the ability of LPS to stimulate
theexpressionofTG, a findingofpotential pathophysiological
implication. (Endocrinology 147: 3260–3275, 2006)
THE ENDOTOXIN LIPOPOLYSACCHARIDE (LPS) is amajor constituent of the outer membrane of Gram-
negative bacteria. LPS is not intrinsically toxic but is one of
the most potent biological response modifiers; picomolar
concentrations are sufficient to stimulate cells from several
systems. The endotoxin mainly induces immune cells to ex-
press a multiplicity of genes. The immunostimulation ex-
erted by LPS principally comprises a marked activation of B
cells with polyclonal antibody production as well as an in-
duction of the expression of various kinds of mediators in-
volved in cellular immunity (1–5). In conditions in which
large amounts of LPS enter the bloodstream because of bac-
teriolysis, a systemic inflammatory overreaction occurs lead-
ing to septic shock (1, 3–5). Several studies have demon-
strated that LPS plays a role as an environmental factor in
some diseases in which autoantibodies or autoantigen-spe-
cific T cells are involved (2, 6). The property of LPS to fa-
cilitate autoimmunity has been applied to develop several
experimental models of autoimmunity (2, 6, 7).
Thyroglobulin (TG) is a key protein for normal thyroid
function. It is the matrix protein where thyroid hormone
synthesis takes place, as well as one of the main thyroid
autoantigens. Thyroid hormonogenesis involves the iodide
uptake by the sodium iodide symporter and the iodination
of TG catalyzed by thyroid peroxidase in the presence of
hydrogen peroxide with later coupling of TG iodotyrosine
residues (8). Thyroid-specific gene expression is predomi-
nantly under regulation of TSH and principally involves
three transcription factors that have a central role, thyroid
transcription factor (TTF)-1 (also named Titf1, NKX 2.1, or
T/EBP), TTF-2 (also named FOXE1), and paired box domain
transcription factor 8 (Pax8) (9, 10). These transcription fac-
tors are present in several tissues (11–14), although they are
expressed together only in the developing and adult thyroid
in a unique combination responsible for the early commit-
ment, differentiation, and maintenance of the differentiated
thyroid state (9, 10). The minimal rat TG promoter able to
respond to TSH comprises a 207-bp fragment extending from
168 to39 relative to the transcription initiation site of the
gene. The elements necessary for cell type-specific transcrip-
tion are contained in a smaller fragment extending from
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168 to 42. In this region, there are three binding sites for
TTF-1, one site for TTF-2, and one for Pax8 that overlaps with
the most 3 sequence recognized by TTF-1 in the element
known as the C site (15–17).
Infectious agents have been implicated in the induction of
thyroid autoimmune disease (18, 19). Experimental autoim-
mune thyroiditis has been extensively induced by TG plus
adjuvants including LPS in mice. However, it was observed
that the disease developed by a different mechanism when
LPS was used as the adjuvant (7, 20). This finding was par-
tially explained by the direct induction of chemokine syn-
thesis by LPS in thyroid cells (7). In a growing number of
reports, an enhanced expression of proteins that act as self-
antigens has been associated with the etiology and pathology
of several autoimmune diseases (21–23). The possibility that
LPS exerts a direct action on the expression of autoantigenic
proteins has, however, not been explored.
This work aimed to study the influence of LPS on TG gene
expression in Fisher rat thyroid cell line (FRTL)-5 thyroid
cells and to examine the underlying mechanisms. Because
LPS affects diverse cell types, FRTL-5 follicular thyroid cells
are particularly useful to examine the direct effect of LPS on
thyrocytes. Here, we demonstrate a novel action of LPS to
increase TSH-induced TG gene expression at the transcrip-
tional level in FRTL-5 thyroid cells. We provide evidence that
the C site in the TG promoter is involved in the stimulatory
action of LPS, possibly through an enhanced TTF-1- and
Pax8-mediated transactivation. LPS induces an increment in
the binding of the transcription factors TTF-1 and Pax8 to the
C site of the TG promoter, as well as an increase in TTF-1 and
Pax8 mRNA and protein expression. The half-lives of TG,
Pax8, and TTF-1 are prolonged in LPS-treated cells. Taken
together, these results indicate that LPS is able to increase the
TG expression in the presence of TSH, a finding that could
have implications for thyroid pathophysiology.
Materials and Methods
Cell culture
FRTL-5 rat thyroid cells (ATCC CRL 8305, American Type Culture
Collection, Manassas, VA) were kindly provided by Dr. L. Kohn (Edison
Biotech Institute, Ohio University, Athens, OH) and had the properties
previously reported (24). Cells were grown in a 5% CO2-95% air atmo-
sphere in Coon’s modified Ham F-12 medium supplemented with 5%
calf serum (DMEM/Ham F-12, 1:1) (PAA Laboratories GmbH, Linz,
Austria), 1 mIU/ml bovine TSH [a generous gift of the National Institute
of Diabetes and Digestive and Kidney Diseases (NIDKK) National Pi-
tuitary Hormone Program and Dr. A. F. Parlow, National Institutes of
Health, Torrance, CA], 10 g/ml bovine insulin, 5 g/ml bovine trans-
ferrin, 2 mol/ml glutamine, antibiotics, and antimycotics (Sigma, St.
Louis, MO). Cells were passaged every 7–8 d and fed fresh medium
every 2–3 d. When they reached 70% of confluence, cells were shifted to
basal medium without TSH containing 0.2% calf serum and maintained
for 5–7 d until the time of the experiments. Starved (basal) cells were
treated with the indicated concentrations of LPS from Escherichia coli
serotype 055:B5 (Sigma) in the presence of 0.5 mIU/ml TSH for different
periods of time. All cultured cells were used before passage 20.
Immunocytochemistry
Cells were cultured in glass coverslips and air dried after the indi-
cated treatments. Subsequently, coverslips were incubated overnight
with an antihuman TG antibody (Sigma) in a solution containing Tris-
buffered saline [50 mm Tris-HCl, 0.88% NaCl (pH 7.6)] and 0.5% BSA in
PBS (1:1), 2 h with a biotinylated anti-IgG antibody (Amersham Phar-
macia Biotech, Piscataway, NJ), followed by 2 h with an extrAvidin-Cy3
conjugate (Sigma). The slides were then counterstained with 1 g/ml
Hoechst solution (25). As a negative control, anti-TG antibody was
omitted in a group of coverslips. The positivity of the reaction was
observed as a red fluorescence by fluorescence microscopy (Eclipse
E600, Nikon, Shinagawa-ku, Japan). The fluorescent reaction was also
analyzed under a confocal laser scanning microscope (LSM 510, Carl
Zeiss, Oberkochen, Germany), fitted with an inverted Axiovert 100M
microscope (Carl Zeiss) and a 40 C-Apochromat objective (Carl Zeiss).
Excitation on the laser scanning confocal microscope was at 543 nm with
a 1-mW helium/neon laser. Optical sections were collected using a
560-nm-long pass filter emission to collect the fluorescence of Cy3. The
fluorescence staining intensity was analyzed by internal LSM 510 and
by MetaMorph softwares (Universal Imaging Corp., Downingtown,
PA).
Whole and nuclear protein extract preparation
For total protein extract preparation, cells were harvested in PBS,
centrifuged, resuspended in whole-cell lysate buffer [50 mmHEPES (pH
7), 2 mm MgCl2, 250 mm NaCl, 0.1 mm EDTA, 0.1 mm EGTA, 0.1%
Nonidet 40, 1 mm dithiothreitol (DTT), 1 mm phenylmethylsulfonylfluo-
ride (PMSF), 10 g/ml pepstatin A, 10 g/ml aprotinin, 10 g/ml
leupeptin] and incubated on ice for 15 min. The lysate was centrifuged,
and the supernatant was collected (26). For nuclear protein extract prep-
aration, cells were collected in buffer A [10 mm HEPES-KOH (pH 7.9),
1.5 mm MgCl2, 10 mm KCl, 0.5 mm DTT, 0.2 mm PMSF], incubated on
ice for 10 min, and centrifuged. The nuclear pellet was resuspended in
buffer C [20 mm HEPES-KOH (pH 7.9), 25% glycerol, 420 mm NaCl, 1.5
mm MgCl2, 0.2 mm EDTA, 0.5 mm DTT, 0.2 mm PMSF] and incubated
on ice for 20 min. Cellular debris was removed by centrifugation, and
the supernatant was collected (27). Protein content was quantified by the
Bradford method (Bio-Rad Laboratories, Inc., Hercules, CA) using BSA
as standard (28).
Western blot analysis
Proteins (25 g) were resolved by 6 or 10% SDS-PAGE for TG or
TTF-1, Pax8, -actin, and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) detection, respectively. Proteins were electrotransferred to
nitrocellulose membranes (Sigma). Ponceau S staining of the blots was
used to control for equal protein loading. Membranes were blocked and
incubated with antihuman TG (Dako, A/S, Golstrup, Denmark), TTF-1
(H-190), or Pax8 (F-19) antibodies cross-reacting with rat TG, TTF-1, or
Pax8, respectively (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) in
0.1% Tween 20-Tris-buffered saline-5% skimmed milk at room temper-
ature. Membranes were washed and then incubated with an anti-IgG-
horseradish peroxidase conjugated antibody (Santa Cruz Biotechnology,
Inc.). Immunoreactive bands were visualized with a luminol Western
blot detection reagent (NEN Life Sciences Products, Boston, MA) as
described by the manufacturer. The intensities of the bands were de-
termined by scanning densitometry (Scion Image software, Scion Cor-
poration, National Institutes of Health). Densitometric values were nor-
malized in relation to the Ponceau S staining in each lane.
Protein half-life analysis
Cells were preincubated with TSH or TSH plus LPS for 24 h. Then,
cells were treated with 10 g/ml cycloheximide (CHX) for the indicated
periods of time and harvested for whole-protein extract preparation and
Western blot analysis as described above. Densitometric measurements
at each time length were plotted and half-lives estimated from the best
fitted equation in each case.
RNA isolation, Northern blot analysis, and RT-PCR
Total RNA was purified from FRTL-5 cells after treatment by the acid
guanidinium thiocyanate/phenol/chloroform extraction procedure of
Chomczynski and Sacchi (29). For Northern blot analysis, total RNA (20
g) was subjected to electrophoresis on 1% agarose gels containing 0.66
m formaldehyde (Sigma). RNA was transferred to nylon membranes
(Sigma) by capillary transblotting overnight. Membranes were baked for
2 h at 80 C and stained with methylene blue to reveal the integrity of
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RNA and sample loading. Hybridization was performed overnight at 42
C in a solution containing 50% formamide and 32P-ATP probes labeled
by the random primer method (30). Rat TG (31), TTF-1 (32), and Pax8
(33) cDNAs were used as probes. RT-PCR was done to estimate the
expression of-actin and GAPDH mRNAs. cDNA was synthesized from
total RNA (1 g), and PCR was performed in a 20-l reaction volume
containing 2 l cDNA, 0.5 m primers, 0.25 mm dNTPs, 1.5 mmMgCl2,
and 0.8 U Taq polymerase. For -actin amplification, the mixed samples
were heated to 95 C for 3 min, and then 21 cycles of amplification were
performed at 95 C for 30 sec, 59 C for 30 sec, and 72 C for 30 sec followed
by a 7-min extension at 72 C. For GAPDH amplification, samples heated
to 94 C for 5 min were subjected to 18 cycles performed at 94 C for 1 min,
63 C for 1 min, and 72 C for 1 min followed by a 10-min extension at 72
C. The primer sequences for -actin (560 bp) were: 5 CGACGAGGC-
CCAGAGCAAGAGAGG (sense) and 5CGTCAGGCAGCTCAT-
AGCTCTTCTCCAGGG (antisense) and for GAPDH (513 bp) were: 5
GAGTATGTCGTGGAGTCTACTG (sense) and 5 GCTTCACCACCT-
TCTTGATGTC (antisense). PCR products were separated on 2% agarose
gels and visualized with ethidium bromide. The intensities of the bands
from Northern blot or RT-PCR assays were determined by scanning
densitometry (Scion Image software, Scion Corp., National Institutes of
Health).
Promoter constructs
The pTG luciferase (Luc) repoter plasmid contained the minimal
wild-type promoter of the rat TG gene (168 to 36 bp), linked to the
Luc gene, and pTG Luc-PMT, the minimal TG promoter mutated in the
Pax8 binding element, both in the pGL2-Basic plasmid (34). The 5C-CAT
construct contained five tandem repeats of the TTF-1/Pax8 binding site
(C site) from the rat TG promoter linked to the chloramphenicol acetyl-
transferase (CAT) gene (35). The pTACAT-3, referred to here as pTG
CAT, corresponded to the minimal wild-type promoter of the rat TG
gene (168 to 39 bp) linked to the CAT gene, and the pTACAT-14,
referred to here as pTG CAT-TMT, contained the minimal TG promoter
mutated in the TTF-1 binding site (15). As negative controls, the pro-
motorless pGL3-Basic (Promega, Madison, WI) and a TATA-box/CAT-
containing plasmid were used. The cytomegalovirus (CMV) promoter-
Luc and CMV- galactosidase (gal) (CMV linked to  gal gene) plasmids
(Promega) were used to monitor transfection efficiency (36, 37).
Transfection assays
FRTL-5 cells were plated at a density of 6 105 per 60-mm-diameter
tissue culture dish 48 h before transfection. The calcium phosphate DNA
coprecipitation method was used for transfections as previously de-
scribed (36, 38). Cells were incubated with the precipitate containing
4-g constructs of interest and 0.8 g CMV-Luc or CMV--gal. Trans-
fected cells were cultured in basal medium for 5 d and then treated with
LPS. After the indicated time, cells were harvested in Tris-EDTA-NaCl
solution [40 mm Tris-HCl (pH 7.5), 1 mm EDTA, 150 mm NaCl], cen-
trifuged, and resuspended in 100 mmKH2PO4 (pH 7.8) containing 1 mm
DTT. Lysates were centrifuged, and the supernatants were assayed for
Luc, CAT, or -gal activities as described (37, 39, 40).
EMSA
EMSAs were performed as previously described (16). Synthesized
double-stranded oligonucleotides C (5-CACTGCCCAGTCAAGTGT-
TCTTGA-3), derived from the specific TTF-1/Pax8 binding C site of the
TG promoter, and two C mutants, Cp (5-TCAGTCACGCGTGACT-
GGGCAGTG-3), which does not bind TTF-1, and Ct (5-ACGATGAGT-
GGCTCATAAATCG-3), which does not bind Pax8 (41), were labeled
with 32P-ATP using the Klenow fragment of DNA polymerase and
purified using Sephadex G25 columns (Sigma). Nuclear extracts (5 g)
were incubated in a 20-l reaction volume on ice in binding mix buffer
containing 40 mm HEPES (pH 7.9), 20 mm KCl, 0.5 mm DTT, 0.2 mm
EDTA, 1 g poly (deoxyinosine-deoxycytosine), and 5% Ficoll. Labeled
oligonucleotide probe (50,000 cpm; approximately 50 pg DNA) was
added, and incubation continued at room temperature. The resulting
DNA-protein complexes were separated from free DNA on a 5% native
polyacrylamide gel in 0.5 Tris borate-EDTA buffer (89 mm Tris, 89 mm
boric acid, 2 mm EDTA), then vacuum dried and exposed to x-ray film.
Autoradiograms whose signal intensity was not in an oversaturated
range were analyzed by scanning densitometry. For competition assays,
a 100-fold excess of cold oligonucleotides C (oligo C), Cp (oligo Cp), or
Ct (oligo Ct) was added to the reaction mixture before adding the labeled
oligonucleotide. In supershift experiments using anti-TTF-1 or anti-Pax8
antibodies (2 g), nuclear extracts were incubated with the antibodies
1 h on ice before adding the labeled probe and then processed as above.
Statistical analysis
Analysis of multiple intergroup differences was conducted by one-
way ANOVA. As posttest, the Student-Newman-Keuls multiple com-
parisons test was used. Comparisons between two groups were made
using the Student’s t test. Differences were considered significant at P
0.05.
Results
LPS increases the TSH-induced TG protein and
mRNA expression
To investigate LPS action on TG expression, basal FRTL-5
cells were treated with TSH in combination with different
concentrations of LPS. TG levels were analyzed by immu-
nofluorescence with confocal microscopy and by Western
blot assays. In laser confocal microscopy pictures, we could
detect TG in the cytoplasm of thyroid cells. Treatment with
LPS did not modify the distribution of TG or the morphology
of thyrocytes (Fig. 1A, a1–d1). The accumulation of TG in the
cytoplasm of thyroid follicular cells was increased after TSH
stimulation (48 h) (Fig. 1A, b1). A greater accumulation of TG
was observed in the presence of TSH plus LPS (Fig. 1A,
c1–d1). Semiquantitative analyses using internal laser scan-
ning microscope (Fig. 1A, a2–d2) and Methamorph softwares
(Fig. 1B) confirmed that LPS induced an increment of TG
expression. The maximal stimulatory effect (1.8-fold in-
crease) was obtained with 0.1g/ml LPS (Fig. 1B). Treatment
with higher LPS concentrations induced a lower increase (1
g/ml LPS; 1.4-fold increase) or did not change (10 g/ml
LPS) TG levels compared with that induced by TSH (data not
shown). Incubation with LPS alone (0.1–10 g/ml) did not
modify TG immunoreactivity in comparison with that of
basal cells (data not shown). The LPS-induced increase of TG
level was confirmed by Western blot (Fig. 2). TSH augmented
TG expression at all analyzed time points with a maximal
effect at 48 h. The presence of LPS stimulated TSH-induced
TG level (24 and 48 h) with a maximal increase at 48 h. After
72 h of LPS incubation, there was no change in TG expression
compared with the TSH-induced level (Fig. 2). Northern blot
assays revealed that the treatment with 0.1 g/ml LPS rap-
idly increased TSH-stimulated TG mRNA expression (3 and
6 h)m with a maximal effect at 3 h of treatment (Fig. 3). Then,
LPS-induced TG mRNA progressively diminished and com-
pared with the TSH-induced level a significant reduction was
detected at 24 and 48 h of incubation, whereas no change was
observed at 72 h of treatment (Fig. 3). In cells treated with
TSH alone, TG mRNA augmented at all analyzed time
points, with a maximal increment at 48 h (Fig. 3). Treatment
with LPS alone did not modify TG protein (Fig. 2) or mRNA
expression (data not shown) compared with basal values,
indicating that the effect of LPS was dependent on the pres-
ence of TSH.
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LPS stimulates TG promoter activity
To study the molecular mechanism by which LPS stimu-
lates TG protein and mRNA expression, we analyzed the
functional activity of the TG promoter. Transient transfection
assays with a construct containing the hormone-responsive
region from168 to36 bp of the minimal rat TG promoter
linked to the Luc gene (pTG Luc) were performed. This
promoter region has three TTF-1, one TTF-2, and one Pax8
binding elements (Fig. 4A) and is sufficient to promote tran-
scription in response to TSH (15–17). We observed that TSH
increased TG promoter activity with a maximal effect at 48 h
(Fig. 4B). LPS (0.01 and 0.1 g/ml) stimulated the TSH-
mediated activation of the TG promoter in a dose-dependent
manner after 18–24 h of treatment (Fig. 4B). The functional
activation of the TG promoter by LPS was in accordance with
the LPS-induced increase of TG protein and mRNA levels
(Figs. 1–3). When LPS was added for 48 h, a significant
repression of the TSH-stimulated promoter activity was ob-
FIG. 1. LPS increases the TSH-stimulated TG accumulation in the thyroid cell. A, TG expression by immunofluorescence method in basal (a1),
TSH alone-treated (b1), TSH 0.01 g/ml LPS-treated (c1), and TSH 0.1 g/ml LPS-treated (d1) cells incubated for 48 h, using confocal laser
scanning microscopy (bar, 20 m). Cy3 brightness intensity scale 0–250 was quantified by LSM 510 laser scanning microscope image system
software (Carl Zeiss) (a2–d2). B, Relative intensity of Cy3 brightness quantified by MetaMorph softwares. Each value represents the mean 
SEM of at least three independent experiments.*,P 0.001 vs.TSHalone; #,P 0.001 vs. basal (taken as 1.00); Student-Newman-Keulsmultiple
comparisons test.
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served (Fig. 4B), a finding consistent with the reduction of TG
protein and mRNA levels observed after longer times of
endotoxin treatment (Figs. 2 and 3). No change in the TG
promoter activity compared with that in basal cells was
found in cells treated only with LPS (Fig. 4B).
The C site is involved in the LPS-induced stimulation of the
TG promoter
Given the transcriptional regulation of TG gene expression
by LPS, the involvement of the C site, one of the main ele-
ments for the binding of thyroid-specific transcription factors
in the TG promoter, was examined. It is known that the C
region is crucial for the full expression of the minimal TG
promoter after TSH stimulation (15, 34). The activity of a
construct containing five tandem repeats of the C site linked
to a TATA box (5C-CAT) was analyzed in transfection assays
(Fig. 5A). A concentration-dependent increase in the TSH-
induced activity of 5C-CAT was observed at 24 and 48 h of
LPS treatment (Fig. 5B). In the presence of LPS alone, the
5C-CAT activity was not modified in comparison with that
obtained in basal conditions (Fig. 5B). These results indicate
that the C element seems to be essentially involved in the
LPS-induced stimulation of the TG promoter.
The Pax8 and TTF-1 binding elements are necessary for the
LPS and TSH responsiveness of the TG promoter activity
Because the C site appears to participate in the LPS action
on the TG promoter and because Pax8 and TTF-1 are known
to be key regulators of TG gene expression through the C
binding (41, 42), we investigated the functional relevance of
the Pax8 and TTF-1 binding sites in the effect of LPS. The
transcriptional activity of a construct with the minimal TG
promoter mutated in the Pax8 binding element of the C site
(pTG Luc-PMT) (34) was analyzed. Because TTF-1 and Pax8
binding sequences overlap at the C site in the TG promoter
(43) and to avoid a potential influence of the mutation on
TTF-1 binding, the construct had the core sequence for TTF-1
binding and four surrounding residues preserved (Fig 6A,
upper). Under these conditions, binding of TTF-1, but not of
Pax8, is possible (34). Confirmation of the specific binding of
this construct by TTF-1 was done by supershift assays; only
TTF-1 from FRTL-5 nuclear proteins binds a 24-bp oligonu-
cleotide derived from the C site of TG promoter containing
the mutation at the Pax8 binding site (oligo C-PMT, 79 to
55) (Fig. 6A, lower). In contrast to the observation with the
wild-type TG minimal promoter, the activity of pTG Luc-
PMT was not altered by LPS. As expected, activity of this
construct was not stimulated by TSH (Fig. 6B). Although the
activity of the mutated promoter in the absence of TSH and
LPS was markedly lower than that of the wild-type, it was
higher compared with the promotorless pGL3-Basic, indi-
cating some TSH and Pax8-independent transcriptional ac-
tivity that was not modified by LPS (Fig. 6B). To study the
functional role of the TTF-1 binding site in mediating LPS
action, we tested the activity of a construct containing the
minimal TG promoter mutated in the core sequence for
TTF-1 binding at the C element (pTG CAT-TMT) (Fig 6A,
upper). Band shift assays with an oligonucleotide derived
from the C site containing the mutation in the TTF-1 binding
element (oligo C-TMT) confirmed that this construct allowed
only the binding of Pax8 (Fig 6A, lower). Similar to the results
observed with the response element mutated at the Pax8
binding site, pTG CAT-TMT did not respond to LPS or TSH
stimulation (Fig. 6C). In the presence of LPS alone, no change
in the activity of the two constructs, pTG Luc-PMT or pTG
CAT-TMT, was observed when compared with the activity
under basal conditions (Fig. 6, B and C). These results indi-
cate that Pax8 and TTF-1 seem to be crucial mediators of the
LPS-induced increase in TG promoter activity.
LPS increases the binding activity of Pax8 and TTF-1 to
the C site in the TG promoter
EMSAs were performed to look for either qualitative or
quantitative LPS-induced changes on the protein binding
activity to the C site in the TG promoter. Nuclear extracts
from cells cultured in the presence of LPS were tested for the
ability to bind a 24-bp oligonucleotide (oligo C) derived from
the C region (82 to 58) of the TG promoter (see Materials
and Methods) (16). We observed a pattern of protein-DNA
complexes mainly composed of two bands that was similar
with nuclear extracts collected under all different treatments
conditions (Fig. 7A). Competition assays with cold oligo C
showed that the two mobility shift bands represented spe-
cific binding to the C site sequence after TSH or TSH plus LPS
treatment (Fig. 7C, lanes 4 and 8). However, only the upper
band was stimulated by TSH in a time-dependent manner
(Fig. 7A, lanes 3, 6, and 9), whereas the lower band presented
a relatively stable intensity in all conditions, including the
basal condition (Fig. 7A). It was apparent that LPS induced
FIG. 2. LPS-induced increase in the TSH-stimulated TG accumula-
tion varies with the time of incubation. Basal FRTL-5 cells were
treated with TSH alone or TSH plus LPS (0.1 g/ml) for different
times (24–72 h). Then, cells then were harvested for whole-protein
extract preparation. A, Representative Western blot of whole-cell
extract (25g) probedwith antihumanTGantibody. B,Densitometric
analysis of the Western blots. Each value represents the mean SEM
of at least three independent experiments. *, P  0.01; **, P  0.001
vs.TSHalone; #,P 0.01 vs. basal (taken as 1.00); Student-Newman-
Keuls multiple comparisons test.
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an increase in the intensity of the TSH-stimulated specific
upper band at all analyzed time points (Fig. 7A, lanes 4, 7,
and 10 vs. lanes 3, 6, and 9, respectively) and that it was
statistically significant (Fig. 7B) with the highest stimulation
compared with TSH alone at 3 h of treatment (Fig. 7, A and
B). The intensity of the bands was not modified by LPS alone
when compared with the one obtained under basal condi-
tions (data not shown). Considering the TSH-dependent abil-
ity of TTF-1 and Pax8 to bind to the C site in the TG promoter
demonstrated by some authors (33, 41), we suspected that the
specific upper band obtained could represent complexes
formed of TTF-1 and Pax8 with the C site. This assumption
is in agreement with previous observations indicating that
under TSH stimulation, both transcription factors form com-
plexes binding to the C site with similar electrophoretic mo-
bility that are detected as a single band by binding assays
(33). Supershift assays with specific antibodies confirmed
that the specific band certainly corresponded to a mixture of
complexes of TTF-1 and Pax8 with the C site (Fig. 7C, lanes
2, 3, 6, and 7). The addition of anti-TTF-1 antibody resulted
in a new retarded complex (Fig. 7C, lanes 2 and 6). Using an
anti-Pax8 antibody in the binding reaction resulted in a re-
duction in the formation of the complex, but there was no
retarded band (Fig. 7C, lanes 3 and 7) because the antibody
used in these experiments recognizes the Pax8 N-terminal
region implicated in DNA binding (43). Supershift assays
corroborated the stimulatory effect of LPS on the binding
activity to the C site for each of the transcription factors Pax8
and TTF-1 because the intensities of the remnant complexes
containing Pax8 and TTF-1 in the presence of anti-TTF-1 or
anti-Pax8 antibody, respectively, were increased by LPS
compared with those obtained with TSH treatment alone
(Fig. 7C, lanes 2 and 6; lanes 3 and 7). The intensity of the
remnant Pax8-C site complex was lower when compared
with the residual TTF-1-C site complex in the presence of
anti-TTF-1 and Pax8 antibodies, respectively, suggesting a
less abundant formation of Pax8-C site complexes in our
system. Although both transcription factors are able to bind
to the C site, the apparently low ability of Pax8 to bind to the
C site is in agreement with previous observations indicating
that Pax8 binds less efficiently than TTF-1 in most experi-
mental conditions (33, 44). To further confirm that LPS stim-
ulates the binding of both factors to the C site, we performed
EMSAs using mutated oligonucleotides able to bind selec-
tively TTF-1 (Ct) or Pax8 (Cp) (Materials and Methods) (41).
The specificity of the oligonucleotides was confirmed in our
experimental system by supershift assays; oligo Ct only
binds TTF-1 and oligo Cp Pax8 in the presence of anti-TTF-1
(Fig. 7D, lanes 2, 4, and 10) or anti-Pax8 (Fig. 7D, lanes 5, 7,
and 9) antibodies. In the presence of Ct and Cp, LPS increased
the TSH-induced binding of TTF-1 (Fig. 7D, lane 3 vs. 1) and
Pax8 (Fig. 7D, lane 8 vs. 6) to the C element, respectively. The
absence of proteins other than TTF-1 and Pax8 binding to the
C site was evident by the lack of remnant complexes when
Ct plus anti-TTF-1 (Fig. 7D, lanes 2 and 4) or Cp plus anti-
Pax8 (Fig. 7D, lanes 7 and 9) antibodies were tested. To
further corroborate the binding specificity and the effect of
LPS, we performed EMSAs using Cp and Ct as cold com-
petitors. Shifted bands permit the estimation of the amount
of TTF-1/oligo C complex and Pax8/oligo C complex in the
presence of an excess of cold Cp and Ct, respectively. We
found that under these conditions, LPS stimulated the TSH-
induced binding of TTF-1 (Fig. 7E, lanes 2 and 5) and Pax8
(Fig. 7E, lanes 3 and 6) to the C site. Based on these results,
FIG. 3. LPS increases the TSH-induced
mRNA TG level. Basal cells were treated
with TSHalone or TSHplus LPS (0.1g/ml)
for different times (3–48 h) and then har-
vested for total RNA extraction. A, Repre-
sentative Northern blot (20 g) hybridized
with a rat TG probe. B, Densitometric anal-
ysis of the Northern blots. Values were nor-
malized with 18S rRNA. Each value repre-
sents the mean  SEM of at least three
independent experiments. *, P  0.01 vs.
TSH alone (increase); , P  0.05; , P 
0.001 vs. TSH alone (decrease); #, P  0.05;
##, P 0.01; ###, P 0.001 vs. basal (taken
as 1.00). Student-Newman-Keuls multiple
comparisons test.
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we conclude that LPS treatment results in an increment of the
TSH-stimulated binding of TTF-1 and Pax8 to the C site of the
TG promoter. Because the pattern of the complexes detected
with LPS was similar to that of TSH alone, no qualitative
modifications in protein binding to the C site appear to be
induced by the endotoxin. The ability of LPS to augment the
binding of thyroid-specific factors to the C site in the TG
promoter could be involved in an increased transactivation
of the TG gene contributing to the higher LPS-induced TG
expression demonstrated here.
LPS increases the TSH-induced Pax8 and TTF-1 mRNA
and protein expression
The expression of Pax8 and TTF-1 mRNA and protein in
response to LPS was also analyzed. TSH induced an up-
regulation of Pax8 mRNA (Fig. 8A) and protein expression
(Fig. 8B) from 3–72 and 12–72 h, respectively. The addition
of LPS induced a rapid increment of the TSH-stimulated Pax8
mRNA level at 3 h that persisted at 6 h and did not differ from
the TSH-induced level at 12 h (Fig. 8A). Then, LPS reduced
Pax8 mRNA expression after 24 and 48 h of incubation,
whereas no change was observed at 72 h of treatment com-
pared with the TSH-stimulated expression (Fig. 8A). The
endotoxin induced an increase of Pax8 protein levels at 12 h
that was maintained at 24 and 48 h of treatment (Fig. 8B). LPS
did not affect TSH-induced Pax8 level after 72 h (Fig. 8B).
With regard to TTF-1 regulation, TSH induced a stimulation
of TTF-1 mRNA at 3 h that persisted at 72 h (Fig. 9A), whereas
an increment in the TTF-1 protein level was observed at 12 h
and maintained until 72 h (Fig. 9B). Under LPS treatment,
TSH-stimulated TTF-1 mRNA was rapidly increased at 3 and
6 h, then progressively decreased displaying a significant
reduction at 24 and 48 h and no change after 72 h of incu-
bation compared with those of TSH alone (Fig. 9A). In con-
trast, the TTF-1 protein amount was markedly increased at
12 h and then slightly decreased, although it remained higher
at 24 and 48 h of incubation compared with TSH-alone treat-
ment (Fig. 9B). No change in TSH-induced TTF-1 level was
observed after incubation with the endotoxin for 72 h (Fig.
9B). Treatment with LPS alone did not modify the Pax8 or
TTF-1 mRNA and protein expression compared with basal
values (data not shown). These results indicate that LPS is
able to stimulate TSH-induced Pax8 and TTF-1 expression in
thyroid follicular cells. Because the endotoxin modifies the
expression of TG, Pax8, and TTF-1 mRNA and protein in a
rather similar way, we tested the specificity of the effect of
LPS by analyzing the expression of the unrelated house-
keeping -actin and GAPDH genes. We observed that LPS
FIG. 4. LPS increases the TG promoter activity. A, Schematic draw-
ing of pTG Luc containing the rat minimal TG promoter linked to Luc
gene as reporter. B, FRTL-5 cells were transfected with 4 g pTG Luc
and 0.8gCMV-gal. After transfection, cellsweremaintained for 5 d
in basal medium and then treated with TSH alone or TSH plus LPS
(0.01–0.1 g/ml) for different times (18–48 h). Relative Luc/gal
activity is expressed as x-fold induction over the value of basal cells.
The data represent the mean  SEM of at least three independent
experiments. *, P 0.05; **, P 0.01 vs. TSH alone (increase); , P
0.05;,P 0.01 vs.TSHalone (decrease); #,P 0.05 vs. basal (taken
as 1.00). Student-Newman-Keuls multiple comparisons test.
FIG. 5. The C element is involved in the LPS-induced increase of the
TG promoter. A, Schematic drawing of 5C-CAT construct containing
five tandem repetitions of theC site linked to TATA-box andCATgene
as reporter. B, FRTL-5 cells were transfected with 4 g 5C-CAT and
0.8 g CMV-Luc. After transfection, cells were maintained for 5 d in
basal medium and then treated with TSH or TSH plus LPS (0.01–0.1
g/ml) for 24 and 48 h. Relative CAT/Luc activity is expressed as
x-fold induction over the value of basal cells. The data represent the
mean  SEM of at least three independent experiments. *, P  0.05;
**, P  0.01; ***, P  0.001 vs. TSH alone; #, P  0.05; ##, P  0.01
vs. basal (taken as 1.00). Student-Newman-Keuls multiple compar-
isons test.
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FIG. 6. The minimal TG promoter mutated in the Pax8 or TTF-1 binding site loses the LPS and TSH responsiveness. A, Region of minimal
TG promoter containing the mutations (underlined) in the Pax8 binding site in gray (pTG Luc-PMT) and in the TTF-1 binding site in bold black
(pTG CAT-TMT); the same region wild type is shown for comparison. Black and gray dots indicate the bases matching those of the TTF-1 and
Pax8 consensus sequences, respectively (upper). The oligonucleotides derived from the mutated region (oligo C-PMT and oligo C-TMT) were
radiolabeled and incubated with nuclear extracts from FRTL-5 cells treated with TSH alone for 24 h. By supershifts with anti-TTF-1 and
anti-Pax8 antibodies, the binding of only TTF-1 to oligo C-PMT or Pax8 to oligo C-TMT was detected (lower). B, Schematic drawing of pTG
Luc-PMT containing the minimal rat TG promoter mutated in the Pax8 binding site linked to Luc gene as reporter (upper). FRTL-5 cells were
transfected with 4 g pTG Luc or its mutant pTG Luc-PMT and 0.8 g CMV-gal. After transfection, the cells were maintained for 5 d in basal
medium and then treated with TSH alone or TSH plus LPS (0.01–0.1 g/ml) for 24 h. Relative Luc/gal activity is expressed as x-fold induction
over the value of basal cells (lower). C, Schematic drawing of pTG CAT-TMT containing the minimal rat TG promoter mutated in the TTF-1
binding site linked to CAT gene as reporter (upper). FRTL-5 cells were transfected with 4 g pTG CAT or its mutant pTG CAT-TMT and 0.8
g CMV-Luc. After transfection, cells were maintained for 5 d in basal medium and then treated with TSH alone or TSH plus LPS (0.01–0.1
g/ml) for 24 h. Relative CAT/Luc activity is expressed as x-fold induction over the value of basal cells (lower). The data represent the mean 
SEM of at least three independent experiments. Cells transfected with pTG Luc or pTG CAT; *, P  0.001 vs. TSH alone; #, P  0.01 vs. basal
(taken as 1.00). Student-Newman-Keuls multiple comparisons test.
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FIG. 7. LPS increases the TSH-stimulated binding of thyroid-specific transcription factors to the C site of the TG promoter. Basal FRTL-5 cells
were treated with TSH alone or TSH plus LPS (0.1 g/ml) for the indicated times. Cells were then harvested for nuclear extract preparation.
EMSAs were performed with a 32P-labeled oligonucleotide corresponding to the TTF-1/Pax8 binding C site (oligo C*) derived from the TG
promoter or its mutants. A, Representative band shift assay. The probe was incubated without (lane 1) or with nuclear extracts from FRTL-5
cells (5 g) (lanes 2–10). B, Densitometric analysis of the EMSAs. Autoradiograms whose signal intensity was into a range not oversaturated
were analyzed by scanning densitometry. The data represent the mean  SEM of at least three independent experiments.*, P  0.05; **, P 
0.01; ***, P  0.001 vs. TSH alone; #, P  0.05; ##, P  0.01 vs. basal (taken as 1.00). Student-Newman-Keuls multiple comparisons test. C,
Representative EMSA; the probe C was incubated without extracts (lane 9) or with nuclear extract from FRTL-5 cells treated for 24 h (5 g)
with TSH (lanes 1–4) or TSH plus LPS (0.1 g/ml) (lanes 5–8) in the presence or absence of anti-hTTF-1 (lanes 2 and 6) or anti-hPax8 (lanes
3 and 7). For competition, a 100-fold excess of cold oligonucleotide C was used (lanes 4 and 8). D, Representative EMSA using the mutant probes
of oligonucleotide C, Ct, which does not bind Pax8 (lanes 1–5) or Cp, which does not bind TTF-1 (lanes 6–10) incubated with nuclear extracts
from FRTL-5 cells treated for 24 h (5 g) with TSH (lanes 1–2 and 6–7) or TSH plus LPS (0.1 g/ml) (lanes 3–5 and 8–10) in the presence of
anti-hTTF-1 (lanes 2, 4, and 10) or anti-hPax8 (lanes 5, 7, and 9). E, Representative EMSA; the probe C was incubated with nuclear extract
from FRTL-5 cells treated for 24 h (5 g) with TSH (lanes 1–3) or TSH plus LPS (0.1 g/ml) (lanes 4–6). In the presence of a 100-fold excess
of cold oligonucleotides Cp and Ct, TTF-1 complex (lanes 2 and 5) and Pax8 complex (lanes 3 and 6) are visualized, respectively.
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did not modify -actin or GAPDH mRNA (Fig. 10, A and C)
or protein (Fig. 10, B and D) levels at any time point analyzed.
These results evidence that LPS does not exert a general
unspecific effect on gene expression in thyrocytes but affects
the expression of the thyroid-specific genes TG, Pax8, and
TTF-1.
FIG. 8. LPS increases the TSH-stimu-
lated Pax8 mRNA and protein expres-
sion. Basal FRTL-5 cells were treated
with TSH alone or TSH plus LPS (0.1
g/ml) for the indicated times and then
harvested for RNA extraction (A) or
whole-protein preparation (B). A, Rep-
resentative Northern blot (20 g) hy-
bridized with a rPax8 probe (upper).
Densitometric analysis of the Northern
blots. Each value represents the
mean  SEM of at least three indepen-
dent experiments. Values were normal-
ized respect to 18S rRNA (lower). B,
Representative Western blot of whole-
cell protein (25 g) probed with an anti-
hPax8 antibody (upper). Densitometric
analysis of the Western blots. Each
value represents the mean  SEM of at
least six independent experiments.
Ponceau S staining was used to correct
loading differences (lower). *, P  0.01;
**, P 0.001 vs. TSH alone; #, P 0.01;
##, P  0.001 vs. basal (taken as 1.00).
Student-Newman-Keuls multiple com-
parisons test.
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TG, Pax8, and TTF-1 half-lives are increased after
LPS treatment
The observation that levels of TG, Pax8, and TTF-1 were
increased while their mRNAs were decreased at the same
time points (24 and 48 h) suggested that LPS could exert
posttranscriptional or posttranslational actions on the ex-
pression of these genes. In an initial attempt to investigate
this point, we evaluated the effect of LPS on the half-lives of
the three proteins. Basal cells were pretreated with TSH or
TSH plus LPS for 24 h and exposed to CHX to block protein
synthesis. As shown in Fig. 11, the half-lives of TG, Pax8, and
TTF-1 were increased in a rather similar proportion after LPS
incubation compared with those of TSH alone. Under these
experimental conditions, the three proteins appear to have a
quite similar half-life after TSH-alone treatment. Values of
half-lives were estimated to be approximately 5.0 h for TG
(Fig. 11A), 5.7 h for Pax8 (Fig. 11B), and 6.9 for TTF-1 (Fig.
11C) in TSH-treated cells. These protein half-lives were in-
FIG. 9. LPS induces an increase in the
TSH-stimulated TTF-1 mRNA and pro-
tein expression. Basal FRTL-5 cells
were treated with TSH alone or TSH
plus LPS (0.1 g/ml) for the indicated
times and then harvested for RNA ex-
traction (A) or whole-protein prepara-
tion (B). A, Representative Northern
blot (20 g) hybridized with a rTTF-1
probe (upper). Densitometric analysis
of the Northern blots. Values were nor-
malized respect to 18S rRNA. Each
value represents the mean  SEM of at
least three independent experiments
(lower). B, Representative Western blot
ofwhole-cell protein (25g) probedwith
an anti-hTTF-1 antibody (upper). Den-
sitometric analysis of the Western
blots. Each value represents the
mean  SEM of at least three indepen-
dent experiments. Ponceau S staining
was used to correct loading differences
(lower). *, P  0.05; **, P  0.01; ***,
P 0.001 vs.TSHalone; #,P 0.05; ##,
P  0.01 vs. basal (taken as 1.00). Stu-
dent-Newman-Keuls multiple compar-
isons test.
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creased by LPS to reach values of approximately 12.0 h for
TG (Fig. 11A), 11.5 h for Pax8 (Fig. 11B), and 16.2 h for TTF-1
(Fig. 11C). These observations are in favor of a posttransla-
tional effect of LPS on TG, Pax8, and TTF-1 that would
involve an increase of the stability of these proteins that could
contribute to the increment of their levels.
Discussion
The present study provides evidence that the bacterial
endotoxin LPS increases TG mRNA and protein levels by
transcriptional activation of the TG gene. The action of LPS
occurs only in TSH-stimulated thyroid cells, suggesting that
FIG. 10. LPS does not modify -actin or GAPDH expression. Basal FRTL-5 cells were treated with TSH alone or TSH plus LPS (0.1 g/ml)
for the indicated times and then harvested for RNA extraction (A and C) or whole-protein preparation (B and D). A, Representative RT-PCR
for -actin (upper). Densitometric analysis of RT-PCR. Each value represents themean SEM of at least three independent experiments (lower).
B, RepresentativeWestern blot of whole-cell protein (25g) probed with an anti--actin antibody (upper). Densitometric analysis of theWestern
blots. Each value represents the mean  SEM of at least three independent experiments. Ponceau S staining was used to correct loading
differences (lower). C, Representative RT-PCR for GAPDH (upper). Densitometric analysis of RT-PCR. Each value represents the mean  SEM
of at least three independent experiments (lower). D, Representative Western blot of whole-cell protein (25 g) probed with an anti-GAPDH
antibody (upper). Densitometric analysis of theWestern blots. Each value represents themean SEM of at least three independent experiments.
Ponceau S staining was used to correct loading differences (lower).
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a cross-talk between the signaling pathways induced by LPS
and TSH may occur. The influence of bacterial endotoxins on
the expression of thyroid-specific genes has not been re-
ported previously. It has, however, been demonstrated that
LPS is able to up-regulate diverse functions in other endo-
crine cells. For example, LPS increases GH mRNA and pro-
tein expression in rat adenohypophysial cells, as well as GH
secretion in vivo (45). An increment in leptin expression and
release from adipose tissue of various species is induced by
LPS (46–48). Recently, evidence that LPS stimulates cortisol
secretion in human adrenocortical cells has been reported
(49). In the present study, the effects of LPS were observed
at rather low, but not at high, concentrations of the endo-
toxin. We therefore expect that the moderate levels of cir-
culating LPS present during certain infectious processes (50)
could be able to induce TG expression in thyroid cells in vivo.
In contrast, high levels of LPS, such as those found in en-
dotoxic shock in humans, may not modify TG expression,
although they have been reported to alter thyroid function by
several other mechanisms (51, 52).
It is well established that LPS induces the expression of
numerous genes in immune cells (1, 3–5). A role of the en-
dotoxin through an immunostimulatory effect has been pro-
posed in autoimmune diseases (2, 6, 7, 20). Several recent
reports have associated the increased expression of proteins
acting as autoantigens with the etiology and pathology of
FIG. 11. LPS increases TG, Pax8, and TTF-1 half-lives. Basal FRTL-5 cells were treated with TSH alone or TSH plus LPS (0.1 g/ml) for 24 h
before incubation with CHX for the indicated times. Protein extracts were assayed for TG (A), Pax8 (B), and TTF-1 (C) levels by Western blot.
Values from densitometric analysis were used for estimation of half-lives. Results are expressed as percent remaining protein; value at 0 h (CHX
addition) is taken as 100%. Each value represents the mean  SEM of at least three independent experiments. Ponceau S staining was used
to correct loading differences.
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diverse autoimmune disorders (21–23). Despite the ability of
LPS to act as a potent biological activator, the possibility that
LPS could modify autoantigen expression in cells that are
target for autoimmunity has not been explored. TG is a key
protein involved in the biosynthesis of thyroid hormones, as
well as one of the major thyroid autoantigens. Experimental
autoimmune thyroiditis has been developed by administra-
tion of TG plus adjuvants in mice. However, a difference in
the pathogenic processes was observed when LPS was used
as the adjuvant (7, 20). This fact was in part explained by the
finding that LPS interacts with the thyrocyte inducing the
expression of several chemokines that, in turn, could facili-
tate lymphocytic infiltration in the thyroid tissue (7). In this
paper, we demonstrate that LPS is able to increase the TSH-
induced TG expression in thyroid cells. The involvement of
TG as an important element to trigger the autoimmune thy-
roid response has been emphasized before (53). Thus, it is
rational to speculate that the LPS-induced TG accumulation
might contribute to antigenic processing of TG by thyroid
cells in the presence of an activated immune system. These
findings would favor the involvement of infectious agents in
the induction of thyroid autoimmune disease (18, 19). De-
spite the intricate mechanisms operating in autoimmunity,
the present results thus could contribute to disclose some
etiopathogenic aspects of thyroid autoimmune disorders.
Here, we demonstrate the functional relevance of the C site
in the TG promoter in the LPS-induced increase of TG gene
transcription. The LPS-stimulating effect seems to be medi-
ated by a higher TTF-1 and Pax8 binding activity to the C site.
It is known that TTF-1 and Pax8 are the main transcription
factors involved in TSH-dependent TG gene expression (9,
10). Accordingly, the present observations confirm the re-
quirement of intact Pax8 and TTF-1 binding sites at the C site
in the TG promoter for TSH- and LPS-induced TG gene
expression. Our results show that the stimulatory action of
LPS appears to take place through a similar mechanism to
that involved in TG gene activation by TSH.
The increment in the C site binding activity of TTF-1 and
Pax8 by LPS that we observed is consistent with the increased
transcriptional activity of 5C-CAT and reinforces a possible
stimulation of the C site-mediated transactivation by these
transcription factors in the TG promoter. The increased bind-
ing of the transcription factors to the C site may be explained
by the stimulatory action displayed by LPS on TTF-1 and
Pax8 expression. However, other mechanisms facilitating the
TTF-1 and Pax8 binding activity to the C site could be in-
volved, although this hypothesis awaits confirmation. For
example, it has been shown that redox state or phosphory-
lation can modify Pax8 and TTF-1 DNA binding activity
through posttranslational modifications (17, 54, 55). The re-
sults presented here reveal that TTF-1 and Pax8 are the main
factors responsible for the LPS-induced TG gene activation.
Although the involvement of some other mediators should
not be discarded, the lack of LPS action on the scarce residual
activity of the TG minimal promoter mutated at the Pax8 or
TTF-1 site argues against a significant role of other factors.
Taking into account that TTF-1 and Pax8 are also expressed
in nonthyroidal tissues where they regulate various target
genes (9, 56–58), one wonders whether LPS could affect other
TTF-1 and Pax8-transactivated genes in other cell types.
An apparent discrepancy between TG mRNA and protein
levels after LPS treatment was observed in this study because
the TSH-stimulated TG mRNA levels were reduced, whereas
the TG protein levels were increased by the endotoxin at the
same time points (24 and 48 h). This fact suggests that the
action of LPS on TSH-induced TG expression is complex,
possibly involving posttranscriptional modifications that
could include changes in TG mRNA stability as well as
changes of TG translation efficiency, degradation, and traf-
ficking. Similar considerations could be made for the appar-
ent lack of parallel changes in Pax8 and TTF-1 mRNA and
protein levels obtained after LPS treatment. Thus, the endo-
toxin decreased TSH-stimulated Pax8 and TTF-1 mRNA lev-
els at 24 and 48 h, whereas it increased simultaneously the
amount of Pax8 and TTF-1 protein levels. These apparent
contradictions may be partially explained by the increase in
the protein half-lives of TG, Pax8, and TTF-1 demonstrated
here. These observations suggest that LPS may alter post-
translational regulation and/or intracellular processing of
these proteins, leading to an increase of protein stability.
Another apparent contradiction was observed between the
TSH-dependent promoter activity that was increased at 24 h
and the TSH-dependent mRNA accumulation that was de-
creased at the same time point by LPS, which may be ex-
plained by the existence of posttranscriptional effects of LPS.
Taken together, these observations support the existence of
multiple levels for the action of LPS on TG, Pax8, and TTF-1
gene expression.
It is known that FRTL-5 cells chronically exposed to TSH
enter a refractory state with no response to further stimula-
tion, an effect explained by a down-regulation of the cAMP-
dependent protein kinase A (59). This is probably one of the
reasons for the decreased stimulatory action of TSH on TG
protein expression after 3 d of TSH treatment observed in our
study. However, at this time, we observed a higher reduction
in the LPS-induced stimulation of TG, a finding that is con-
sistent with the faster and marked diminution of the stim-
ulatory action by LPS on TG mRNA expression and promoter
transcription. This fact might, in part, be explained by a more
rapid entry of cells into a refractory state due to a higher
stimulation of LPS-induced signaling pathways. Several re-
ports suggest that TG is able to autoregulate thyroid hor-
mone biosynthesis by modulating sodium iodide symporter,
thyroid peroxidase, and TG gene expression (8, 60, 61).
Therefore, one might speculate that the LPS-induced eleva-
tion of TG protein levels observed here might also participate
in its autorepression. Of note, the expression of the 5C con-
struct was stimulated by LPS at the same time point we found
a repression of the wild-type promoter (48 h), which suggests
that the region responsible for repression is localized in the
minimal promoter and might be situated upstream of the C
site. This observation would be consistent with a possible
involvement of TG in its autorepression because a previous
report indicated that the TG-induced suppression of a TG-
CAT construct was lost when most of the 5-upstream TTF-1
and TTF-2 sites of the TG minimal promoter were deleted,
but the C site was conserved (60). The apparent contradiction
between the decrease of both TG promoter activity at 48 h
and mRNA levels at 24 and 48 h induced by LPS, despite the
LPS-induced increase of TTF-1 and Pax8 binding to the C site
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at 48 h, would favor negative regulation of the TG gene by
regions upstream of the C site in the TG promoter.
In conclusion, our results reveal for the first time the ability
of the endotoxin LPS to up-regulate TSH-stimulated TG gene
expression at the transcriptional level in thyroid follicular
cells. The presented evidence indicates that the stimulatory
action of LPS could occur, at least in part, through a C
site-mediated increase of TG promoter transactivation in-
volving the transcription factors TTF-1 and Pax8. A further
action of LPS on TG at the posttranslational level was evi-
denced. Because TG is an essential protein for thyroid hor-
mone biosynthesis and one of the main thyroid autoantigens,
these findings suggest a possible role of the endotoxin as a
potential modifier of thyroid function, a fact of possible
pathophysiological relevance. We also demonstrate a novel
action of LPS to increase TTF-1 and Pax8 expression, an effect
that may be relevant for TTF-1- and Pax8-regulated genes in
other cell types.
Acknowledgments
We thank Drs. G. J. Juvenal (Department of Radiobiology, University
of Buenos Aires, Buenos Aires, Argentina), R. Di Lauro (Stazione Zoo-
logica Anton Dohrn, University of Naples Federico II, Naples, Italy), and
T. Onaya (Third Department of Internal Medicine, Faculty of Medicine,
University of Yamanashi, Yamanashi, Japan) for cDNAs and promoter
constructions.
Received June 28, 2005. Accepted April 7, 2006.
Address all correspondence and requests for reprints to: Ana M.
Masini-Repiso, Centro de Investigaciones en Bioquı´mica Clı´nica e In-
munologı´a (CIBICI)-Consejo Nacional de Investigaciones Cientı´ficas y
Te´cnicas (CONICET), Departamento de Bioquı´mica Clı´nica, Facultad de
Ciencias Quı´micas, Universidad Nacional de Co´rdoba, Haya de la Torre
y Medina Allende, 5000 Co´rdoba, Argentina. E-mail: amasini@fcq.unc.
edu.ar.
This work was supported by the Consejo Nacional de Investigaciones
Cientı´ficas y Te´cnicas, by the Secretarı´a de Ciencia y Tecnologı´a de la
Universidad Nacional de Co´rdoba, by the Agencia Co´rdoba Ciencia, by
the Agencia Nacional de Promocio´n Cientı´fica y Tecnolo´gica (Argen-
tina), by Ministerio de Educacio´n y Ciencia, Grant Biologı´a Fundamental
2004-03169, and by Fondo de Investigaciones Sanitarias of the Instituto
de Salud Carlos III, Grant RCMN-C03/08 (Spain).
M.L.V., L.F., M.M.M., and A.M.L. are Doctoral Fellows at Consejo
Nacional de Investigaciones Cientı´ficas y Te´cnicas and CIBICI. E.C. is a
Postdoctoral fellow at Fundacio´n Carolina, Spain. C.G.P. and A.H.C. are
established researchers at Consejo Nacional de Investigaciones Cientı´-
ficas y Te´cnicas. A.M.M.-R. is an established researcher at Depto Bioq
Clı´nica, Facultad de Ciencias Quı´micas, Universidad Nacional de Co´r-
doba, CIBICI-Consejo Nacional de Investigaciones Cientı´ficas y Te´cni-
cas. E.T.K. is an established researcher at the Department of Cell and
Developmental Biology, Institute of Biomedical Science, University of
Sao Paulo (Sao Paulo, Brazil). P.S. is an established researcher at the
Instituto de Investigaciones Biome´dicas (Madrid, Spain).
Results from this work were presented in part at the 13th Interna-
tional Thyroid Congress, Buenos Aires, Argentina, 2005.
References
1. Ulevitch RJ, Tobias PS 1995 Receptor-dependent mechanisms of cell stimu-
lation by bacterial endotoxin. Annu Rev Immunol 13:437–457
2. Yoshino S, Sasatomi E, Ohsawa M 2000 Bacterial lipopolysaccharide acts as
an adjuvant to induce autoimmune arthritis in mice. Immunology 99:607–614
3. Guha M, Mackman N 2001 LPS induction of gene expression in human
monocytes. Cell Signal 13:85–94
4. Erridge C, Bennett-Guerrero E, Poxton IR 2002 Structure and function of
lipopolysaccharides. Microbes Infect 4:837–851
5. Palsson-McDermott EM, O’Neill LA 2004 Signal transduction by the lipo-
polysaccharide receptor, Toll-like receptor-4. Immunology 113:153–162
6. Balasa B, Van Gunst K, Sarvetnick N 2000 The microbial product lipopoly-
saccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/
NOD mice: implications for the etiology of autoimmune diabetes. Clin Im-
munol 95:93–98
7. Damotte D, Goulvestre C, Charreire J, Carnaud C 2003 LPS and Freund’s
adjuvant initiate different inflammatory circuits in experimental autoimmune
thyroiditis. Cytokine Netw 14:52–59
8. Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, ReedM, Ginter CS,
Carrasco N 2003 The sodium/iodide symporter (NIS): characterization, reg-
ulation, and medical significance. Endocr Rev 24:48–77
9. Damante G, Tell G, Di Lauro R 2001 A unique combination of transcription
factors controls differentiation of thyroid cells. Prog Nucleic Acids Res Mol Biol
66:307–356
10. De FeliceM,Di Lauro R 2004 Thyroid development and its disorders: genetics
and molecular mechanisms. Endocr Rev 25:722–746
11. Plachov D, Chowdhury K, Walther C, Simon D, Guenet JL, Gruss P 1990
Pax8, a murine paired box gene expressed in the developing excretory system
and thyroid gland. Development 110:643–651
12. Lazzaro D, Price M, De Felice M, Di Lauro R 1991 The transcription factor
TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in
restricted regions of the fetal brain. Development 113:1093–1104
13. Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, Ward JM,
Gonzalez FJ 1996 The T/ebp null mouse: thyroid-specific enhancer-binding
protein is essential for the organogenesis of the thyroid, lung, ventral forebrain,
and pituitary. Genes Dev 10:60–69
14. Zannini M, Avantaggiato V, Biffali E, Arnone MI, Sato K, Pischetola M,
Taylor BA, Phillips SJ, Simeone A, Di Lauro R 1997 TTF-2, a new forkhead
protein, shows a temporal expression in the developing thyroid which is
consistent with a role in controlling the onset of differentiation. EMBO J
16:3185–3197
15. Sinclair AJ, Lonigro R, Civitareale D, Ghibelli L, Di Lauro R 1990 The
tissue-specific expression of the thyroglobulin gene requires interaction be-
tween thyroid-specific and ubiquitous factors. Eur J Biochem 193:311–318
16. Santisteban P, Acebron A, Polycarpou-Schwarz M, Di Lauro R 1992 Insulin
and insulin-like growth factor I regulate a thyroid-specific nuclear protein that
binds to the thyroglobulin promoter. Mol Endocrinol 6:1310–1317
17. Kambe F, Nomura Y, Okamoto T, Seo H 1996 Redox regulation of thyroid-
transcription factors, Pax8 and TTF-1, is involved in their increased DNA-
binding activities by thyrotropin in rat thyroid FRTL-5 cells. Mol Endocrinol
10:801–812
18. DeGroot LJ, Quintans J 1989 The causes of autoimmune thyroid disease.
Endocr Rev 10:537–562
19. Harii N, Lewis CJ, Vasko V, McCall K, Benavides-Peralta U, Sun X, Ringel
MD, Saji M, Giuliani C, Napolitano G, Goetz DJ, Kohn LD 2005 Thyrocytes
express a functional toll-like receptor 3: overexpression can be induced by viral
infection and reversed by phenylmethimazole and is associated with Hashi-
moto’s autoimmune thyroiditis. Mol Endocrinol 19:1231–1250
20. Zaccone P, Fehervari Z, Cooke A 2003 Tumour necrosis factor- is a funda-
mental cytokine in autoimmune thyroid disease induced by thyroglobulin and
lipopolysaccharide in interleukin-12 p40 deficient C57BL/6 mice. Immunology
108:50–54
21. Pieters K, Pettersson A, Gullberg U, Hellmark T 2004 The 564 A/G poly-
morphism in the promoter region of the proteinase 3 gene associated with
Wegener’s granulomatosis does not increase the promoter activity. Clin Exp
Immunol 138:266–270
22. Casciola-Rosen L, Nagaraju K, Plotz P, Wang K, Levine S, Gabrielson E,
Corse A, Rosen A 2005 Enhanced autoantigen expression in regenerating
muscle cells in idiopathic inflammatory myopathy. J Exp Med 201:591–601
23. Gerl V, Hostmann B, Johnen C, Waka A, Gerl M, Schumann F, Klein R,
Radbruch A, Hiepe F 2005 The intracellular 52-kd Ro/SSA autoantigen in
keratinocytes is up-regulated by tumor necrosis factor  via tumor necrosis
factor receptor I. Arthritis Rheum 52:531–538
24. Ambesi-Impiombato FS, Parks LA, Coon HG 1980 Culture of hormone-
dependent functional epithelial cells from rat thyroids. Proc Natl Acad Sci USA
77:3455–3459
25. Martins L, Matsuo SE, Ebina KN, Kulcsar MA, Friguglietti CU, Kimura ET
2002 Galectin-3 messenger ribonucleic acid and protein are expressed in benign
thyroid tumors. J Clin Endocrinol Metab 87:4806–4810
26. Hirai A, Nakamura S, Noguchi Y, Yasuda T, Kitagawa M, Tatsuno I, Oeda
T, Tahara K, Terano T, Narumiya S, Kohn LD, Saito Y 1997 Geranylgera-
nylated rho small GTPase(s) are essential for the degradation of p27Kip1 and
facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5
cells. J Biol Chem 272:13–16
27. Andrews NC, Faller DV 1991 A rapid micropreparation technique for extrac-
tion of DNA-binding proteins from limiting numbers of mammalian cells.
Nucleic Acids Res 19:2499
28. Bradford MM 1976 A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye binding.
Anal Biochem 72:248–254
29. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid
guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:
156–159
3274 Endocrinology, July 2006, 147(7):3260–3275 Ve´lez et al. • LPS Stimulates TG Gene by Involving TTF-1 and Pax8
 by on May 27, 2010 endo.endojournals.orgDownloaded from 
30. Sambrook J, Fritsch EF, Maniatis T 1989 Molecular cloning. A laboratory
manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory
31. Di Lauro R, Obici S, Acquaviva AM, Alvino CG 1982 Construction of re-
combinant plasmids containing rat thyroglobulin mRNA sequences. Gene
19:117–125
32. Guazzi S, Price M, De Felice M, Damante G, Mattei MG, Di Lauro R 1990
Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel
DNA binding specificity. EMBO J 9:3631–3639
33. Zannini M, Francis-Lang H, Plachov D, Di Lauro R 1992 Pax8, a paired
domain-containing protein, binds to a sequence overlapping the recognition
site of a homeodomain and activates transcription from two thyroid-specific
promoters. Mol Cell Biol 12:4230–4241
34. Kang HC, Ohmori M, Harii N, Endo T, Onaya T 2001 Pax8 is essential for
regulation of the thyroglobulin gene by transforming growth factor-1. En-
docrinology 142:267–275
35. De Felice M, Damante G, Zannini M, Francis-Lang H, Di Lauro R 1995
Redundant domains contribute to the transcriptional activity of the thyroid
transcription factor 1. J Biol Chem 270:26649–26656
36. MedinaDL, RivasM, Cruz P, Barroso I, Regadera J, Santisteban P 2002 RhoA
activation promotes transformation and loss of thyroid cell differentiation
interfering with thyroid transcription factor-1 activity. Mol Endocrinol 16:
33–44
37. Endo T, Kaneshige M, Nakazato M, Ohmori M, Harii N, Onaya T 1997
Thyroid transcription factor-1 activates the promoter activity of rat thyroid
Na/I-symporter gene. Mol Endocrinol 11:1747–1755
38. Chen C, Okayama H 1988 Calcium phosphate-mediated gene transfer: a
highly efficient transfection system for stably transforming cells with plasmid
DNA. Biotechniques 6:632–639
39. Brasier AR, Tate JE, Habener JF 1989 Optimized use of the firefly luciferase
assay as a reporter gene in mammalian cell lines. Biotechniques 7:1116–1122
40. Gorman CM, Moffat LF, Howard BH 1982 Recombinant genomes which
express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol
2:1044–1051
41. FabbroD, Pellizzari L,Mercuri F, TellG,DamanteG 1998 Pax-8 protein levels
regulate thyroglobulin gene expression. J Mol Endocrinol 21:347–354
42. Pasca di Magliano M, Di Lauro R, Zannini M 2000 Pax8 has a key role in
thyroid cell differentiation. Proc Natl Acad Sci USA 97:13144–13149
43. Di Palma T, Nitsch R, Mascia A, Nitsch L, Di Lauro R, Zannini M 2003 The
paired domain-containing factor Pax8 and the homeodomain-containing fac-
tor TTF-1 directly interact and synergistically activate transcription. J Biol
Chem 278:3395–3402
44. Rivas M, Mellstrom B, Naranjo JR, Santisteban P 2004 Transcriptional re-
pressor DREAM interacts with thyroid transcription factor-1 and regulates
thyroglobulin gene expression. J Biol Chem 279:33114–33122
45. Priego T, Granado M, Ibanez de Caceres I, Martin AI, Villanua MA, Lopez-
Calderon A 2003 Endotoxin at low doses stimulates pituitary GH whereas it
decreases IGF-I and IGF-binding protein-3 in rats. J Endocrinol 179:107–117
46. Grunfeld C, Zhao C, Fuller J, Pollack A, Moser A, Friedman J, Feingold KR
1996 Endotoxin and cytokines induce expression of leptin, the ob gene product,
in hamsters. J Clin Invest 97:2152–2157
47. Francis J, MohanKumar PS, MohanKumar SM, Quadri SK 1999 Systemic
administration of lipopolysaccharide increases plasma leptin levels: blockade
by soluble interleukin-1 receptor. Endocrine 10:291–295
48. Landman RE, Puder JJ, Xiao E, Freda PU, Ferin M, Wardlaw SL 2003 Endo-
toxin stimulates leptin in the human and nonhuman primate. J Clin Endocrinol
Metab 88:1285–1291
49. Vakharia K, Hinson JP 2005 Lipopolysaccharide directly stimulates cortisol
secretion by human adrenal cells by a cyclooxygenase-dependent mechanism.
Endocrinology 146:1398–1402
50. Opal SM 2002 The clinical relevance of endotoxin in human sepsis: a critical
analysis. J Endotoxin Res 8:473–476
51. Fekete C, Gereben B, DoleschallM, Harney JW, Dora JM, Bianco AC, Sarkar
S, Liposits Z, RandW, Emerson C, Kacskovics I, Larsen PR, Lechan RM 2004
Lipopolysaccharide induces type 2 iodothyronine deiodinase in the medio-
basal hypothalamus: implications for the nonthyroidal illness syndrome. En-
docrinology 145:1649–1655
52. BoleenA,Kwakkel J, Thijssen-TimmerDC,AlkemadeA, Fliers E,Wiersinga
WM 2004 Simultaneous changes in central and peripheral components of the
hypothalamus-pituitary-thyroid axis in lipopolysaccharide-induced acute ill-
ness in mice. J Endocrinol 182:315–323
53. McLachlan SM, Rapoport B 2004 Why measure thyroglobulin autoantibodies
rather than thyroid peroxidase autoantibodies? Thyroid 14:510–520
54. ZanniniM,AcebronA,De FeliceM,ArnoneMI,Martin-Perez J, Santisteban
P, Di Lauro R 1996 Mapping and functional role of phosphorylation sites in
the thyroid transcription factor-1 (TTF-1). J Biol Chem 271:2249–2254
55. Poleev A, Okladnova O, Musti AM, Schneider S, Royer-Pokora B, Plachov
D 1997 Determination of functional domains of the human transcription factor
PAX8 responsible for its nuclear localization and transactivating potential. Eur
J Biochem 247:860–869
56. Yi M, Tong GX, Murry B, Mendelson CR 2002 Role of CBP/p300 and SRC-1
in transcriptional regulation of the pulmonary surfactant protein-A (SP-A)
gene by thyroid transcription factor-1 (TTF-1). J Biol Chem 277:2997–3005
57. Liu C, Glasser SW, Wan H, Whitsett JA 2002 GATA-6 and thyroid transcrip-
tion factor-1 directly interact and regulate surfactant protein-C gene expres-
sion. J Biol Chem 277:4519–4525
58. Carroll TJ, Vize PD 1999 Synergism between Pax-8 and lim-1 in embryonic
kidney development. Dev Biol 214:46–59
59. OhnoM,ZanniniM, LevyO,CarrascoN,Di LauroR 1999 The paired-domain
transcription factor Pax8 binds to the upstream enhancer of the rat sodium/
iodide symporter gene and participates in both thyroid-specific and cyclic-
AMP-dependent transcription. Mol Cell Biol 19:2051–2060
60. Suzuki K, Lavaroni S, Mori A, Ohta M, Saito J, Pietrarelli M, Singer DS,
Kimura S, Katoh R, Kawaoi A, Kohn LD 1998 Autoregulation of thyroid-
specific gene transcription by thyroglobulin. Proc Natl Acad Sci USA 95:8251–
8256
61. Kohn LD, Suzuki K, Nakazato M, Royaux I, Green ED 2001 Effects of
thyroglobulin and pendrin on iodide flux through the thyrocyte. Trends En-
docrinol Metab 12:10–16
Endocrinology is published monthly by The Endocrine Society (http://www.endo-society.org), the foremost professional society serving the
endocrine community.
Ve´lez et al. • LPS Stimulates TG Gene by Involving TTF-1 and Pax8 Endocrinology, July 2006, 147(7):3260–3275 3275
 by on May 27, 2010 endo.endojournals.orgDownloaded from 
